Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer.
Philip PA; Mahoney MR; Allmer C; Thomas J; Pitot HC; Kim G; Donehower RC; Fitch T; Picus J; Erlichman C; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2005, vol. 23, issue 27, p 6657, ISSN 0732183x. ISBN 0732183x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef